Shidong Xu

3.9k total citations · 1 hit paper
39 papers, 1.1k citations indexed

About

Shidong Xu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Shidong Xu has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Shidong Xu's work include Lung Cancer Diagnosis and Treatment (12 papers), Lung Cancer Treatments and Mutations (12 papers) and Lung Cancer Research Studies (6 papers). Shidong Xu is often cited by papers focused on Lung Cancer Diagnosis and Treatment (12 papers), Lung Cancer Treatments and Mutations (12 papers) and Lung Cancer Research Studies (6 papers). Shidong Xu collaborates with scholars based in China, United States and Sweden. Shidong Xu's co-authors include Jianlong Bu, Yubo Yan, Xianglong Kong, Fenghai Ren, Dawei Sun, Jinfeng Ning, Junfeng Wang, Xuhai Zhao, Mengfeng Liu and Hai Xu and has published in prestigious journals such as Journal of Clinical Oncology, The Science of The Total Environment and Biochemical and Biophysical Research Communications.

In The Last Decade

Shidong Xu

39 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

circRNA-002178 act as a ceRNA to promote PDL1/PD1 expression in lung adenocarcinoma

2020 305 citations Yubo Yan, Xianglong Kong et al. Cell Death and Disease profile →

Peers

Countries citing papers authored by Shidong Xu

Since Specialization

Citations

This map shows the geographic impact of Shidong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shidong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shidong Xu more than expected).

Fields of papers citing papers by Shidong Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shidong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shidong Xu. The network helps show where Shidong Xu may publish in the future.

Co-authorship network of co-authors of Shidong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Shidong Xu. A scholar is included among the top collaborators of Shidong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shidong Xu. Shidong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety of one 8.5-Fr pigtail catheter for postoperative continuous open gravity drainage after uniportal video-assisted thoracoscopic surgery pneumonectomy 2024 ·Journal of Cardiothoracic Surgery ·Xianglong Kong, Yue Zhang, (unknown), (unknown), (unknown), Xiangyuan Jin, (unknown), Shidong Xu	1
2	Osimertinib as neoadjuvant therapy in patients with EGFR-mutant resectable stage II-IIIB lung adenocarcinoma (NEOS): A multicenter, single-arm, open-label phase 2b trial 2023 ·Lung Cancer ·Chao Lv, Wentao Fang, Nan Wu, Wenjie Jiao, Shidong Xu, (unknown), Jia Wang, Rui Wang, Chunyu Ji, Shaolei Li, Yuzhao Wang, Yan Shi, (unknown), Yuquan Pei, Yinan Liu, Yue Yang	47
3	Shenlingcao oral liquid for patients with non-small cell lung cancer receiving adjuvant chemotherapy after radical resection: A multicenter randomized controlled trial 2023 ·Phytomedicine ·Yanmei Liu, (unknown), Jiali Liu, Yu Ma, Jing Tan, Wen Wang, Jian Hu, Xiangning Fu, Xu Lin, Fenglei Yu, Shidong Xu, Haitao Ma, Xiuyi Yu, Qingjun You, Zhi‐Qiang Wang, Ling Li, Xun Zhang, Xin Sun	7
4	Updated Overall Survival and Exploratory Analysis From Randomized, Phase II EVAN Study of Erlotinib Versus Vinorelbine Plus Cisplatin Adjuvant Therapy in Stage IIIA Epidermal Growth Factor Receptor+ Non–Small-Cell Lung Cancer 2022 ·Journal of Clinical Oncology ·Dongsheng Yue, Shidong Xu, Qun Wang, Xiaofei Li, Yi Shen, Heng Zhao, Chun Chen, Weimin Mao, Wei Liu, Junfeng Liu, Lanjun Zhang, Haitao Ma, Qiang Li, Yue Yang, Yongyu Liu, Haiquan Chen, Zhenfa Zhang, Bin Zhang, Changli Wang	37
5	Technical aspects and early results of uniportal video-assisted thoracoscopic complex segmentectomy: a 30 case-series study 2022 ·Journal of Cardiothoracic Surgery ·Xianglong Kong, (unknown), (unknown), (unknown), Kaibin Zhu, (unknown), Shidong Xu	3
6	MiR-139-5p Targetedly Regulates YAF2 and Mediates the AKT/P38 MAPK Signaling Pathway to Alleviate the Metastasis of Non-Small Cell Lung Cancer Cells and Their Resistance Against Cisplatin 2021 ·Cancer Management and Research ·Yubo Yan, Xiangyuan Jin, Haobo Sun, (unknown), (unknown), (unknown), Shidong Xu	10
7	Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer 2021 ·Cell Death and Disease ·(unknown), Jinfeng Ning, Imoh S. Okon, Xiaoxu Zheng, (unknown), Ping Song, Shidong Xu, Ming‐Hui Zou	41
8	Risk factors for lymph node metastasis and surgical scope in patients with cN0 non-small cell lung cancer: a single-center study in China 2021 ·Journal of Cardiothoracic Surgery ·Jianlong Bu, (unknown), (unknown), (unknown), (unknown), Jinfeng Ning, Shidong Xu	8
9	Prediction of Pleural Invasion in Challenging Non-Small-Cell Lung Cancer Patients Using Serum and Imaging Markers 2020 ·Disease Markers ·Kaibin Zhu, (unknown), Changjun He, Yaoguo Lang, Xianglong Kong, Changfa Qu, Shidong Xu	5
10	Effects of wogonoside on invasion and migration of lung cancer A549 cells and angiogenesis in xenograft tumors of nude mice 2020 ·Journal of Thoracic Disease ·Yubo Yan, Lei Yao, Haobo Sun, (unknown), Xianglong Kong, Su Zhao, Shidong Xu	14
11	Synergistic Effect of Hexaphenoxycyclotriphosphazene and Aluminium Tri-Hydroxide on Flame Retardancy and Smoke Suppression of Epoxy Resin 2018 ·Australian Journal of Chemistry ·(unknown), Baolin Wu, Shidong Xu, Po Hu	6
12	Erlotinib versus vinorelbine plus cisplatin as adjuvant therapy in Chinese patients with stage IIIA EGFR mutation-positive non-small-cell lung cancer (EVAN): a randomised, open-label, phase 2 trial 2018 ·The Lancet Respiratory Medicine ·Dongsheng Yue, Shidong Xu, Qun Wang, Xiaofei Li, Yi Shen, Heng Zhao, Chun Chen, Weimin Mao, Wei Liu, Junfeng Liu, Lanjun Zhang, Haitao Ma, Qiang Li, Yue Yang, Yongyu Liu, Haiquan Chen, Changli Wang	177
13	Refining androstenedione and bisnorcholenaldehyde from mother liquor of phytosterol fermentation using macroporous resin column chromatography followed by crystallization 2017 ·Journal of Chromatography B ·Shidong Xu, (unknown), (unknown), (unknown), (unknown)	2
14	MicroRNA-429 induces tumorigenesis of human non-small cell lung cancer cells and targets multiple tumor suppressor genes 2014 ·Biochemical and Biophysical Research Communications ·(unknown), Shidong Xu, Jianqun Ma, Jun Wu, Jin Shi, Shoubo Cao, Yan Yu	48
15	MicroRNA-378 is associated with non-small cell lung cancer brain metastasis by promoting cell migration, invasion and tumor angiogenesis 2011 ·Medical Oncology ·(unknown), Shidong Xu, Hai Xu, Jinfeng Zhang, Jinfeng Ning, Shengfa Wang	131
16	Design of Xinjiang Plant Germplasm Resources Database System 2010 ·Xinjiang nongye kexue ·Shidong Xu	1
17	Complications of open stent-graft in treatment of aortic dissection 2008 ·Interactive Cardiovascular and Thoracic Surgery ·Shidong Xu, (unknown), (unknown), (unknown)	2
18	Endovascular repair after stent elephant trunk procedure for extensive thoracic aortic aneurysm 2008 ·Interactive Cardiovascular and Thoracic Surgery ·Shidong Xu, (unknown), (unknown), (unknown)	1
19	A study of aortic dimension in type B aortic dissection 2007 ·Interactive Cardiovascular and Thoracic Surgery ·Shidong Xu, (unknown), (unknown), (unknown), (unknown), Jian Yang, (unknown), (unknown)	35
20	Epidemiological evaluations of the efficacy of slow-released praziquantel-medicated bars for dogs in the prevention and control of cystic echinococcosis in man and animals 2005 ·Parasitology International ·Wei Jiao, Cheng Fu, (unknown), (unknown), Shidong Xu, Lifeng Sun, (unknown), (unknown), Lingling Han, (unknown), Jie Peng, (unknown), (unknown), (unknown)	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact